XML 34 R23.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
FAIR VALUE MEASUREMENTS (Tables)
9 Months Ended
Mar. 31, 2024
Fair Value Disclosures [Abstract]  
Schedule of fair value contingent consideration
Schedule of fair value contingent consideration     
Stock Price  $2.65 
Exercise Price   $0.46 - $4.50 
Volatility   109% - 140% 
Risk Free Rate   4.11% - 5.26% 
Expected Dividends   0%
Discount Rate (Monte-Carlo model only)   12%
Expected Term (years)   0.439.75 

  

At initial recognition of the contingent consideration, the inputs were:

  

Stock Price  $1.92 
Exercise Price   $0.46 - $4.50 
Volatility   107% - 133%  
Risk Free Rate   4.22% - 5.14% 
Expected Dividends   0%
Discount Rate (Monte-Carlo model only)   12%
Expected Term (years)   0.569.88 
Schedule of consolidated balance sheet at fair value on a recurring basis
Schedule of consolidated balance sheet at fair value on a recurring basis               
   Fair Value Measurements at
Reporting Date Using
   Quoted Prices in
Active Markets for Identical Assets Inputs
  Significant Other
Observable Inputs
  Significant Other Unobservable Inputs
   (Level 1)  (Level 2)  (Level 3)
          
The roll forward of the contingent consideration liability is as follows:               
Balance June 30, 2023          $ 
Contingent consideration in Acquisition           20,557,500 
Fair value adjustment           (486,500)
Contingent Consideration Liability at March 31, 2024          $20,071,000